Less Ads, More Data, More Tools Register for FREE

Pin to quick picksALM.L Regulatory News (ALM)

  • There is currently no data for ALM

Transaction in Own Shares

4 Aug 2021 07:00

RNS Number : 4711H
Allied Minds PLC
04 August 2021
 

4 August 2021

 

Allied Minds

 

Transaction in own shares

 

Allied Minds plc (AIM:ALM, 'Allied Minds' or 'the Company') announces that, in accordance with the terms of its share buyback programme announced on 23 June 2021 ("Share Buyback Programme"), the Company purchased the following number of its Ordinary Shares of £0.01 each ("Ordinary Shares") through Numis Securities Limited. The Ordinary Shares purchased will be cancelled.

 

Date of purchase:

 3 August 2021

Aggregate number of Ordinary Shares purchased:

79,075

Lowest price paid per share (GBp):

20.100

Highest price paid per share (GBp):

20.500

Average price paid per share (GBp):

20.4642

 

Following the purchase of these shares, the remaining number of Ordinary Shares in issue will be 239,884,714 (excluding treasury shares), and the Company hold no Ordinary Shares in treasury. Therefore, the total voting rights in the Company will be 239,884,714. This figure for the total number of voting rights may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation), the table below contains detailed information of the individual trades made by Numis Securities Limited as part of the Share Buyback Programme.

 

Schedule of Purchases - Individual Transactions

 

Number of ordinary shares purchased

Transaction price(GBp share)

Time of transaction (UK Time)

Transaction reference number

Trading venue

1756

20.50

08:37:42

00053036872TRLO0

LSE

485

20.50

13:27:59

00053050578TRLO0

LSE

5000

20.50

13:27:59

00053050580TRLO0

LSE

3093

20.50

13:27:59

00053050581TRLO0

LSE

6533

20.50

13:42:24

00053050996TRLO0

LSE

4498

20.50

13:42:24

00053050997TRLO0

LSE

6533

20.50

14:02:50

00053051672TRLO0

LSE

1240

20.50

14:02:50

00053051673TRLO0

LSE

6533

20.50

14:27:50

00053052481TRLO0

LSE

2182

20.50

14:27:50

00053052482TRLO0

LSE

6533

20.50

14:57:50

00053054359TRLO0

LSE

1823

20.50

14:57:50

00053054360TRLO0

LSE

1670

20.50

15:10:50

00053054902TRLO0

LSE

6202

20.50

15:10:50

00053054903TRLO0

LSE

331

20.50

15:29:50

00053056129TRLO0

LSE

7854

20.50

15:29:50

00053056130TRLO0

LSE

6533

20.50

15:39:50

00053056606TRLO0

LSE

2028

20.50

15:39:50

00053056607TRLO0

LSE

1130

20.50

15:46:12

00053056868TRLO0

LSE

43

20.50

15:47:44

00053056937TRLO0

LSE

7075

20.10

16:27:50

00053059058TRLO0

LSE

 

 

For more information, please contact:

 

Allied Minds plc

c/o Instinctif Partners

Harry Rein

Instinctif

alliedminds@instinctif.com

Tim Linacre / Rozi Morris / Hannah Campbell

 

 

About Allied Minds

Allied Minds plc is an IP commercialisation company focused on early stage company development within the technology sector. With origination relationships that span US federal laboratories, universities, and leading US corporations, Allied Minds historically created, and now operates and funds, a portfolio of companies to generate long-term value for its investors and stakeholders. Based in Boston, Allied Minds supports its businesses with capital, management, expertise and shared services. For more information, please visit www.alliedminds.com.

 

 

###

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSKZGGRVFDGMZM
Date   Source Headline
7th Dec 201812:02 pmRNSPrice Monitoring Extension
6th Dec 201812:02 pmRNSPrice Monitoring Extension
4th Dec 20187:00 amRNSHawkEye 360 successful pathfinder satellite launch
12th Nov 20187:00 amRNSSpin Memory series B and commercial partnerships
9th Nov 20185:09 pmRNSBlocklisting Six Monthly Return
9th Nov 20185:05 pmRNSBlocklisting Six Monthly Return
27th Sep 20187:00 amRNSHalf-year Report
24th Sep 20187:00 amRNSSTT announces appointment of Chairman
18th Sep 20187:00 amRNSAllied Minds forms QuayChain subsidiary
10th Sep 20187:00 amRNSHawkEye 360 completes second Series A-3 funding
10th Sep 20187:00 amRNSBridgeSat raises $10.0 million Series B financing
10th Sep 20187:00 amRNSFederated Wireless update
15th Aug 20184:35 pmRNSPrice Monitoring Extension
13th Aug 20187:03 amRNSNotice of Results
13th Aug 20187:00 amRNSHawkEye 360 raises $9.6m in Series A-3 financing
11th Jul 20184:35 pmRNSPrice Monitoring Extension
11th Jul 20187:00 amRNSPrecision Biopsy appoints Chief Operating Officer
2nd Jul 20183:15 pmRNSTotal Voting Rights
26th Jun 20185:17 pmRNSDirector/PDMR Shareholding
19th Jun 20184:54 pmRNSDirector/PDMR Shareholding
19th Jun 20184:48 pmRNSDirector/PDMR Shareholding
19th Jun 20184:38 pmRNSDirector/PDMR Shareholding
12th Jun 201811:12 amRNSDirector/PDMR Shareholding
31st May 20187:00 amRNSDirectorate Change
23rd May 20183:30 pmRNSResult of AGM
23rd May 20187:00 amRNSTrading Statement
16th May 20181:25 pmRNSDirector/PDMR Shareholding
16th May 201811:24 amRNSDirector/PDMR Shareholding
16th May 201810:51 amRNSDirector/PDMR Shareholding
16th May 20187:00 amRNSFederated Wireless Update
11th May 20189:38 amRNSBlocklisting Six Monthly Return
11th May 20189:31 amRNSBlocklisting Six Monthly Return
1st May 20183:09 pmRNSHolding(s) in Company
9th Apr 20188:25 amRNSAllied Minds leads funding round at TableUp
9th Apr 20188:25 amRNSAllied Minds leads Orbital Sidekick funding round
6th Apr 20187:00 amRNSNotice of AGM and Annual Report
3rd Apr 201811:26 amRNSTotal Voting Rights
22nd Mar 20187:01 amRNSDirectorate Change
22nd Mar 20187:00 amRNSAnnual Financial Report
8th Mar 20187:00 amRNSNotice of Results
1st Mar 20182:17 pmRNSTotal Voting Rights
1st Feb 201810:20 amRNSTotal Voting Rights
22nd Jan 20183:25 pmRNSDirector/PDMR Shareholding
22nd Jan 20183:22 pmRNSDirector/PDMR Shareholding
18th Jan 20187:00 amRNSCapital Markets Day Materials
17th Jan 20187:00 amRNSAllied Minds: Sale of Percipient Networks
11th Jan 20187:00 amRNSSTT's $22.8m convertible bridge facility
19th Dec 201712:02 pmRNSPrice Monitoring Extension
18th Dec 20177:00 amRNSSciFluor: results of phase 1/2 study of SF0166
30th Nov 201712:12 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.